Holland O B
Drugs. 1984 Oct;28 Suppl 1:86-92. doi: 10.2165/00003495-198400281-00009.
In the past, adverse cardiac effects of potassium depletion in non-digitalised patients and in patients without cardiac disease were considered to be minimal. However, several studies have now demonstrated a significant incidence of ventricular ectopic activity in diuretic-treated patients, particularly in those who become hypokalaemic. Potassium repletion with potassium-sparing diuretics or with potassium chloride supplementation has generally demonstrated a beneficial therapeutic effect in reducing ventricular ectopic activity. However, occasional patients may have persistent ventricular ectopic activity after diuretic therapy which may result from focal myocardial lesions associated with potassium depletion. In addition, factors other than potassium depletion appear to initiate or magnify diuretic-induced ventricular ectopic activity. Thus, to avoid these adverse cardiac effects, normokalaemia should be maintained during long term diuretic therapy.
过去,人们认为非洋地黄化患者和无心脏病患者中钾缺乏的不良心脏影响极小。然而,现在多项研究表明,接受利尿剂治疗的患者,尤其是出现低钾血症的患者,室性异位活动的发生率很高。使用保钾利尿剂或补充氯化钾来补充钾,通常已证明在减少室性异位活动方面具有有益的治疗效果。然而,少数患者在利尿剂治疗后可能会出现持续性室性异位活动,这可能是由与钾缺乏相关的局灶性心肌病变引起的。此外,除钾缺乏外的其他因素似乎也会引发或加剧利尿剂诱发的室性异位活动。因此,为避免这些不良心脏影响,在长期利尿剂治疗期间应维持血钾正常。